Related Experiment Videos
[ELISA method for the determination of factor VII antigen]
Sangre
|December 1, 1989
Summary
Assaying clotting factor VII (F VII) antigen is challenging due to low plasma levels. An improved enzyme immunoassay (ELISA) method offers high sensitivity for F VII:Ag detection and characterization.
Area of Science:
- Biochemistry
- Immunology
- Hematology
Context:
- Clotting factor VII (F VII) is crucial for hemostasis.
- Low F VII plasma concentrations complicate traditional antigenic fraction assays.
- Commercial availability of peroxidase-conjugated antisera enables immunoassay development.
Purpose:
- To develop a sensitive enzyme-linked immunosorbent assay (ELISA) for quantifying clotting factor VII antigen (F VII:Ag).
- To establish a reliable method for characterizing F VII molecular variants and acquired deficiencies.
Summary:
- A novel ELISA method was developed to overcome limitations in assaying low plasma F VII concentrations.
- This assay achieves sensitivity limits of approximately 0.1% of plasma F VII concentration.
- The ELISA results show a significant correlation with F VII functional activity (r = 0.603, p < 0.001).
Impact:
- Facilitates accurate characterization of molecular variants of clotting factor VII.
- Enables the detection of acquired deficiencies in clotting factor VII.
- Provides a valuable tool for hematological research and clinical diagnostics.